
Combovir combines nirmatrelvir 150 mg with ritonavir 100 mg for the early treatment of mild-to-moderate COVID-19. It is prescribed to eligible patients who have a higher risk of serious illness, hospitalisation or other complications.
| Manufacturer | Bruck Pharma Private Limited |
| Generic Name | Nirmatrelvir/Ritonavir |
| Strength | 150 mg + 100 mg |
| Pack size | 10 mg + 20 Tablets |
| Used For | COVID-19 |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Saudi Arabia, Qatar, Kuwait, and many other countries. |

Authentic Medicines

Fast Delivery

Secure Payment

24/7 Support
Nirmatrelvir interferes with a viral enzyme required by SARS-CoV-2 to make new proteins and reproduce. Ritonavir slows the metabolism of nirmatrelvir, allowing it to remain at an effective level in the body for a longer period.
Disclaimer
All information on this website is for educational purposes only. Medicines should be used only with a doctor’s prescription and supervision. We do not provide medical advice, and product details may change without notice. Always consult a healthcare professional before using any medication.